img

Global Hormone Disorder Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Hormone Disorder Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Hormone Disorder Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hormone Disorder Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Dwarfism and Gigantism are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Hormone Disorder Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Hormone Disorder Drug key manufacturers include Teva Pharmaceutical Industries Ltd, Amneal Pharmaceutical Inc, Mayne Pharma Group Limited, Merck KGaA, Sanofi, Sun Pharmaceutical Industries Ltd, Novartis AG, F. Hoffmann-La Roche Ltd and Abbott, etc. Teva Pharmaceutical Industries Ltd, Amneal Pharmaceutical Inc, Mayne Pharma Group Limited are top 3 players and held % sales share in total in 2022.
Hormone Disorder Drug can be divided into Growth Hormone Stimulator and Growth Hormone Inhibitor, etc. Growth Hormone Stimulator is the mainstream product in the market, accounting for % sales share globally in 2022.
Hormone Disorder Drug is widely used in various fields, such as Dwarfism, Gigantism and Other,, etc. Dwarfism provides greatest supports to the Hormone Disorder Drug industry development. In 2022, global % sales of Hormone Disorder Drug went into Dwarfism filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hormone Disorder Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Teva Pharmaceutical Industries Ltd
Amneal Pharmaceutical Inc
Mayne Pharma Group Limited
Merck KGaA
Sanofi
Sun Pharmaceutical Industries Ltd
Novartis AG
F. Hoffmann-La Roche Ltd
Abbott
PT. Daewoong Pharmaceutical Company
Genentech, Inc
Bausch Health Companies Inc
Lilly
Ipsen Pharma
Ferring B.V
Segment by Type
Growth Hormone Stimulator
Growth Hormone Inhibitor

Segment by Application


Dwarfism
Gigantism
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hormone Disorder Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hormone Disorder Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hormone Disorder Drug industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Hormone Disorder Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hormone Disorder Drug introduction, etc. Hormone Disorder Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Hormone Disorder Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Hormone Disorder Drug Market Overview
1.1 Hormone Disorder Drug Product Overview
1.2 Hormone Disorder Drug Market Segment by Type
1.2.1 Growth Hormone Stimulator
1.2.2 Growth Hormone Inhibitor
1.3 Global Hormone Disorder Drug Market Size by Type
1.3.1 Global Hormone Disorder Drug Market Size Overview by Type (2024-2034)
1.3.2 Global Hormone Disorder Drug Historic Market Size Review by Type (2024-2024)
1.3.3 Global Hormone Disorder Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hormone Disorder Drug Sales Breakdown by Type (2024-2024)
1.4.2 Europe Hormone Disorder Drug Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Hormone Disorder Drug Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Hormone Disorder Drug Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Hormone Disorder Drug Sales Breakdown by Type (2024-2024)
2 Global Hormone Disorder Drug Market Competition by Company
2.1 Global Top Players by Hormone Disorder Drug Sales (2024-2024)
2.2 Global Top Players by Hormone Disorder Drug Revenue (2024-2024)
2.3 Global Top Players by Hormone Disorder Drug Price (2024-2024)
2.4 Global Top Manufacturers Hormone Disorder Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hormone Disorder Drug Market Competitive Situation and Trends
2.5.1 Hormone Disorder Drug Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Hormone Disorder Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hormone Disorder Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Hormone Disorder Drug Market
2.8 Key Manufacturers Hormone Disorder Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hormone Disorder Drug Status and Outlook by Region
3.1 Global Hormone Disorder Drug Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Hormone Disorder Drug Historic Market Size by Region
3.2.1 Global Hormone Disorder Drug Sales in Volume by Region (2024-2024)
3.2.2 Global Hormone Disorder Drug Sales in Value by Region (2024-2024)
3.2.3 Global Hormone Disorder Drug Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Hormone Disorder Drug Forecasted Market Size by Region
3.3.1 Global Hormone Disorder Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Hormone Disorder Drug Sales in Value by Region (2024-2034)
3.3.3 Global Hormone Disorder Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Hormone Disorder Drug by Application
4.1 Hormone Disorder Drug Market Segment by Application
4.1.1 Dwarfism
4.1.2 Gigantism
4.1.3 Other
4.2 Global Hormone Disorder Drug Market Size by Application
4.2.1 Global Hormone Disorder Drug Market Size Overview by Application (2024-2034)
4.2.2 Global Hormone Disorder Drug Historic Market Size Review by Application (2024-2024)
4.2.3 Global Hormone Disorder Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hormone Disorder Drug Sales Breakdown by Application (2024-2024)
4.3.2 Europe Hormone Disorder Drug Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Hormone Disorder Drug Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Hormone Disorder Drug Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Hormone Disorder Drug Sales Breakdown by Application (2024-2024)
5 North America Hormone Disorder Drug by Country
5.1 North America Hormone Disorder Drug Historic Market Size by Country
5.1.1 North America Hormone Disorder Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Hormone Disorder Drug Sales in Volume by Country (2024-2024)
5.1.3 North America Hormone Disorder Drug Sales in Value by Country (2024-2024)
5.2 North America Hormone Disorder Drug Forecasted Market Size by Country
5.2.1 North America Hormone Disorder Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Hormone Disorder Drug Sales in Value by Country (2024-2034)
6 Europe Hormone Disorder Drug by Country
6.1 Europe Hormone Disorder Drug Historic Market Size by Country
6.1.1 Europe Hormone Disorder Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Hormone Disorder Drug Sales in Volume by Country (2024-2024)
6.1.3 Europe Hormone Disorder Drug Sales in Value by Country (2024-2024)
6.2 Europe Hormone Disorder Drug Forecasted Market Size by Country
6.2.1 Europe Hormone Disorder Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Hormone Disorder Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Hormone Disorder Drug by Region
7.1 Asia-Pacific Hormone Disorder Drug Historic Market Size by Region
7.1.1 Asia-Pacific Hormone Disorder Drug Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Hormone Disorder Drug Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Hormone Disorder Drug Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Hormone Disorder Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Hormone Disorder Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Hormone Disorder Drug Sales in Value by Region (2024-2034)
8 Latin America Hormone Disorder Drug by Country
8.1 Latin America Hormone Disorder Drug Historic Market Size by Country
8.1.1 Latin America Hormone Disorder Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Hormone Disorder Drug Sales in Volume by Country (2024-2024)
8.1.3 Latin America Hormone Disorder Drug Sales in Value by Country (2024-2024)
8.2 Latin America Hormone Disorder Drug Forecasted Market Size by Country
8.2.1 Latin America Hormone Disorder Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Hormone Disorder Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Hormone Disorder Drug by Country
9.1 Middle East and Africa Hormone Disorder Drug Historic Market Size by Country
9.1.1 Middle East and Africa Hormone Disorder Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Hormone Disorder Drug Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Hormone Disorder Drug Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Hormone Disorder Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Hormone Disorder Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Hormone Disorder Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Teva Pharmaceutical Industries Ltd
10.1.1 Teva Pharmaceutical Industries Ltd Company Information
10.1.2 Teva Pharmaceutical Industries Ltd Introduction and Business Overview
10.1.3 Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Products Offered
10.1.5 Teva Pharmaceutical Industries Ltd Recent Development
10.2 Amneal Pharmaceutical Inc
10.2.1 Amneal Pharmaceutical Inc Company Information
10.2.2 Amneal Pharmaceutical Inc Introduction and Business Overview
10.2.3 Amneal Pharmaceutical Inc Hormone Disorder Drug Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Amneal Pharmaceutical Inc Hormone Disorder Drug Products Offered
10.2.5 Amneal Pharmaceutical Inc Recent Development
10.3 Mayne Pharma Group Limited
10.3.1 Mayne Pharma Group Limited Company Information
10.3.2 Mayne Pharma Group Limited Introduction and Business Overview
10.3.3 Mayne Pharma Group Limited Hormone Disorder Drug Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Mayne Pharma Group Limited Hormone Disorder Drug Products Offered
10.3.5 Mayne Pharma Group Limited Recent Development
10.4 Merck KGaA
10.4.1 Merck KGaA Company Information
10.4.2 Merck KGaA Introduction and Business Overview
10.4.3 Merck KGaA Hormone Disorder Drug Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Merck KGaA Hormone Disorder Drug Products Offered
10.4.5 Merck KGaA Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Information
10.5.2 Sanofi Introduction and Business Overview
10.5.3 Sanofi Hormone Disorder Drug Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Sanofi Hormone Disorder Drug Products Offered
10.5.5 Sanofi Recent Development
10.6 Sun Pharmaceutical Industries Ltd
10.6.1 Sun Pharmaceutical Industries Ltd Company Information
10.6.2 Sun Pharmaceutical Industries Ltd Introduction and Business Overview
10.6.3 Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Products Offered
10.6.5 Sun Pharmaceutical Industries Ltd Recent Development
10.7 Novartis AG
10.7.1 Novartis AG Company Information
10.7.2 Novartis AG Introduction and Business Overview
10.7.3 Novartis AG Hormone Disorder Drug Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Novartis AG Hormone Disorder Drug Products Offered
10.7.5 Novartis AG Recent Development
10.8 F. Hoffmann-La Roche Ltd
10.8.1 F. Hoffmann-La Roche Ltd Company Information
10.8.2 F. Hoffmann-La Roche Ltd Introduction and Business Overview
10.8.3 F. Hoffmann-La Roche Ltd Hormone Disorder Drug Sales, Revenue and Gross Margin (2024-2024)
10.8.4 F. Hoffmann-La Roche Ltd Hormone Disorder Drug Products Offered
10.8.5 F. Hoffmann-La Roche Ltd Recent Development
10.9 Abbott
10.9.1 Abbott Company Information
10.9.2 Abbott Introduction and Business Overview
10.9.3 Abbott Hormone Disorder Drug Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Abbott Hormone Disorder Drug Products Offered
10.9.5 Abbott Recent Development
10.10 PT. Daewoong Pharmaceutical Company
10.10.1 PT. Daewoong Pharmaceutical Company Company Information
10.10.2 PT. Daewoong Pharmaceutical Company Introduction and Business Overview
10.10.3 PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Sales, Revenue and Gross Margin (2024-2024)
10.10.4 PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Products Offered
10.10.5 PT. Daewoong Pharmaceutical Company Recent Development
10.11 Genentech, Inc
10.11.1 Genentech, Inc Company Information
10.11.2 Genentech, Inc Introduction and Business Overview
10.11.3 Genentech, Inc Hormone Disorder Drug Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Genentech, Inc Hormone Disorder Drug Products Offered
10.11.5 Genentech, Inc Recent Development
10.12 Bausch Health Companies Inc
10.12.1 Bausch Health Companies Inc Company Information
10.12.2 Bausch Health Companies Inc Introduction and Business Overview
10.12.3 Bausch Health Companies Inc Hormone Disorder Drug Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Bausch Health Companies Inc Hormone Disorder Drug Products Offered
10.12.5 Bausch Health Companies Inc Recent Development
10.13 Lilly
10.13.1 Lilly Company Information
10.13.2 Lilly Introduction and Business Overview
10.13.3 Lilly Hormone Disorder Drug Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Lilly Hormone Disorder Drug Products Offered
10.13.5 Lilly Recent Development
10.14 Ipsen Pharma
10.14.1 Ipsen Pharma Company Information
10.14.2 Ipsen Pharma Introduction and Business Overview
10.14.3 Ipsen Pharma Hormone Disorder Drug Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Ipsen Pharma Hormone Disorder Drug Products Offered
10.14.5 Ipsen Pharma Recent Development
10.15 Ferring B.V
10.15.1 Ferring B.V Company Information
10.15.2 Ferring B.V Introduction and Business Overview
10.15.3 Ferring B.V Hormone Disorder Drug Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Ferring B.V Hormone Disorder Drug Products Offered
10.15.5 Ferring B.V Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hormone Disorder Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hormone Disorder Drug Industrial Chain Analysis
11.4 Hormone Disorder Drug Market Dynamics
11.4.1 Hormone Disorder Drug Industry Trends
11.4.2 Hormone Disorder Drug Market Drivers
11.4.3 Hormone Disorder Drug Market Challenges
11.4.4 Hormone Disorder Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hormone Disorder Drug Distributors
12.3 Hormone Disorder Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Growth Hormone Stimulator
Table 2. Major Company of Growth Hormone Inhibitor
Table 3. Global Hormone Disorder Drug Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Hormone Disorder Drug Sales by Type (2024-2024) & (K Units)
Table 5. Global Hormone Disorder Drug Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Hormone Disorder Drug Sales by Type (2024-2024) & (US& Million)
Table 7. Global Hormone Disorder Drug Market Share in Value by Type (2024-2024)
Table 8. Global Hormone Disorder Drug Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Hormone Disorder Drug Sales by Type (2024-2034) & (K Units)
Table 10. Global Hormone Disorder Drug Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Hormone Disorder Drug Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Hormone Disorder Drug Sales Market Share in Value by Type (2024-2034)
Table 13. Global Hormone Disorder Drug Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Hormone Disorder Drug Sales by Type (2024-2024) & (K Units)
Table 15. North America Hormone Disorder Drug Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Hormone Disorder Drug Sales (K Units) by Type (2024-2024)
Table 17. Europe Hormone Disorder Drug Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Hormone Disorder Drug Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Hormone Disorder Drug Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Hormone Disorder Drug Sales (K Units) by Type (2024-2024)
Table 21. Latin America Hormone Disorder Drug Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Hormone Disorder Drug Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Hormone Disorder Drug Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Hormone Disorder Drug Sales by Company (2024-2024) & (K Units)
Table 25. Global Hormone Disorder Drug Sales Share by Company (2024-2024)
Table 26. Global Hormone Disorder Drug Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Hormone Disorder Drug Revenue Share by Company (2024-2024)
Table 28. Global Market Hormone Disorder Drug Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Hormone Disorder Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Hormone Disorder Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hormone Disorder Drug as of 2022)
Table 32. Date of Key Manufacturers Enter into Hormone Disorder Drug Market
Table 33. Key Manufacturers Hormone Disorder Drug Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Hormone Disorder Drug Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Hormone Disorder Drug Sales by Region (2024-2024) & (K Units)
Table 37. Global Hormone Disorder Drug Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Hormone Disorder Drug Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Hormone Disorder Drug Sales Market Share in Value by Region (2024-2024)
Table 40. Global Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Hormone Disorder Drug Sales by Region (2024-2034) & (K Units)
Table 42. Global Hormone Disorder Drug Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Hormone Disorder Drug Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Hormone Disorder Drug Sales Market Share in Value by Region (2024-2034)
Table 45. Global Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Hormone Disorder Drug Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Hormone Disorder Drug Sales by Application (2024-2024) & (K Units)
Table 48. Global Hormone Disorder Drug Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Hormone Disorder Drug Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Hormone Disorder Drug Sales Market Share in Value by Application (2024-2024)
Table 51. Global Hormone Disorder Drug Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Hormone Disorder Drug Sales by Application (2024-2034) & (K Units)
Table 53. Global Hormone Disorder Drug Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Hormone Disorder Drug Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Hormone Disorder Drug Sales Market Share in Value by Application (2024-2034)
Table 56. Global Hormone Disorder Drug Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Hormone Disorder Drug Sales by Application (2024-2024) (K Units)
Table 58. North America Hormone Disorder Drug Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Hormone Disorder Drug Sales by Application (2024-2024) (K Units)
Table 60. Europe Hormone Disorder Drug Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Hormone Disorder Drug Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Hormone Disorder Drug Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Hormone Disorder Drug Sales by Application (2024-2024) (K Units)
Table 64. Latin America Hormone Disorder Drug Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Hormone Disorder Drug Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Hormone Disorder Drug Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Hormone Disorder Drug Sales by Country (2024-2024) & (K Units)
Table 68. North America Hormone Disorder Drug Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Hormone Disorder Drug Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Hormone Disorder Drug Sales Market Share in Value by Country (2024-2024)
Table 71. North America Hormone Disorder Drug Sales by Country (2024-2034) & (K Units)
Table 72. North America Hormone Disorder Drug Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Hormone Disorder Drug Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Hormone Disorder Drug Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Hormone Disorder Drug Sales by Country (2024-2024) & (K Units)
Table 76. Europe Hormone Disorder Drug Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Hormone Disorder Drug Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Hormone Disorder Drug Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Hormone Disorder Drug Sales by Country (2024-2034) & (K Units)
Table 80. Europe Hormone Disorder Drug Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Hormone Disorder Drug Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Hormone Disorder Drug Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Hormone Disorder Drug Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Hormone Disorder Drug Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Hormone Disorder Drug Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Hormone Disorder Drug Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Hormone Disorder Drug Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Hormone Disorder Drug Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Hormone Disorder Drug Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Hormone Disorder Drug Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Hormone Disorder Drug Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Hormone Disorder Drug Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Hormone Disorder Drug Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Hormone Disorder Drug Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Hormone Disorder Drug Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Hormone Disorder Drug Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Hormone Disorder Drug Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Hormone Disorder Drug Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Hormone Disorder Drug Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Hormone Disorder Drug Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Hormone Disorder Drug Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Hormone Disorder Drug Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Hormone Disorder Drug Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Hormone Disorder Drug Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Hormone Disorder Drug Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Hormone Disorder Drug Sales Market Share in Value by Country (2024-2034)
Table 107. Teva Pharmaceutical Industries Ltd Company Information
Table 108. Teva Pharmaceutical Industries Ltd Introduction and Business Overview
Table 109. Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Product
Table 111. Teva Pharmaceutical Industries Ltd Recent Development
Table 112. Amneal Pharmaceutical Inc Company Information
Table 113. Amneal Pharmaceutical Inc Introduction and Business Overview
Table 114. Amneal Pharmaceutical Inc Hormone Disorder Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Amneal Pharmaceutical Inc Hormone Disorder Drug Product
Table 116. Amneal Pharmaceutical Inc Recent Development
Table 117. Mayne Pharma Group Limited Company Information
Table 118. Mayne Pharma Group Limited Introduction and Business Overview
Table 119. Mayne Pharma Group Limited Hormone Disorder Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Mayne Pharma Group Limited Hormone Disorder Drug Product
Table 121. Mayne Pharma Group Limited Recent Development
Table 122. Merck KGaA Company Information
Table 123. Merck KGaA Introduction and Business Overview
Table 124. Merck KGaA Hormone Disorder Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Merck KGaA Hormone Disorder Drug Product
Table 126. Merck KGaA Recent Development
Table 127. Sanofi Company Information
Table 128. Sanofi Introduction and Business Overview
Table 129. Sanofi Hormone Disorder Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Sanofi Hormone Disorder Drug Product
Table 131. Sanofi Recent Development
Table 132. Sun Pharmaceutical Industries Ltd Company Information
Table 133. Sun Pharmaceutical Industries Ltd Introduction and Business Overview
Table 134. Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Product
Table 136. Sun Pharmaceutical Industries Ltd Recent Development
Table 137. Novartis AG Company Information
Table 138. Novartis AG Introduction and Business Overview
Table 139. Novartis AG Hormone Disorder Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Novartis AG Hormone Disorder Drug Product
Table 141. Novartis AG Recent Development
Table 142. F. Hoffmann-La Roche Ltd Company Information
Table 143. F. Hoffmann-La Roche Ltd Introduction and Business Overview
Table 144. F. Hoffmann-La Roche Ltd Hormone Disorder Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. F. Hoffmann-La Roche Ltd Hormone Disorder Drug Product
Table 146. F. Hoffmann-La Roche Ltd Recent Development
Table 147. Abbott Company Information
Table 148. Abbott Introduction and Business Overview
Table 149. Abbott Hormone Disorder Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Abbott Hormone Disorder Drug Product
Table 151. Abbott Recent Development
Table 152. PT. Daewoong Pharmaceutical Company Company Information
Table 153. PT. Daewoong Pharmaceutical Company Introduction and Business Overview
Table 154. PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Product
Table 156. PT. Daewoong Pharmaceutical Company Recent Development
Table 157. Genentech, Inc Company Information
Table 158. Genentech, Inc Introduction and Business Overview
Table 159. Genentech, Inc Hormone Disorder Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. Genentech, Inc Hormone Disorder Drug Product
Table 161. Genentech, Inc Recent Development
Table 162. Bausch Health Companies Inc Company Information
Table 163. Bausch Health Companies Inc Introduction and Business Overview
Table 164. Bausch Health Companies Inc Hormone Disorder Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. Bausch Health Companies Inc Hormone Disorder Drug Product
Table 166. Bausch Health Companies Inc Recent Development
Table 167. Lilly Company Information
Table 168. Lilly Introduction and Business Overview
Table 169. Lilly Hormone Disorder Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 170. Lilly Hormone Disorder Drug Product
Table 171. Lilly Recent Development
Table 172. Ipsen Pharma Company Information
Table 173. Ipsen Pharma Introduction and Business Overview
Table 174. Ipsen Pharma Hormone Disorder Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 175. Ipsen Pharma Hormone Disorder Drug Product
Table 176. Ipsen Pharma Recent Development
Table 177. Ferring B.V Company Information
Table 178. Ferring B.V Introduction and Business Overview
Table 179. Ferring B.V Hormone Disorder Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 180. Ferring B.V Hormone Disorder Drug Product
Table 181. Ferring B.V Recent Development
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Hormone Disorder Drug Market Trends
Table 185. Hormone Disorder Drug Market Drivers
Table 186. Hormone Disorder Drug Market Challenges
Table 187. Hormone Disorder Drug Market Restraints
Table 188. Hormone Disorder Drug Distributors List
Table 189. Hormone Disorder Drug Downstream Customers
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Hormone Disorder Drug Product Picture
Figure 2. Global Hormone Disorder Drug Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Hormone Disorder Drug Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Hormone Disorder Drug Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Growth Hormone Stimulator
Figure 6. Global Growth Hormone Stimulator Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Growth Hormone Inhibitor
Figure 8. Global Growth Hormone Inhibitor Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Hormone Disorder Drug Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Hormone Disorder Drug Sales Market Share by Type in 2022 & 2034
Figure 11. North America Hormone Disorder Drug Sales Market Share in Volume by Type in 2022
Figure 12. North America Hormone Disorder Drug Sales Market Share in Value by Type in 2022
Figure 13. Europe Hormone Disorder Drug Sales Market Share in Volume by Type in 2022
Figure 14. Europe Hormone Disorder Drug Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Hormone Disorder Drug Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Hormone Disorder Drug Sales Market Share in Value by Type in 2022
Figure 17. Latin America Hormone Disorder Drug Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Hormone Disorder Drug Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Hormone Disorder Drug Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Hormone Disorder Drug Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Hormone Disorder Drug Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Hormone Disorder Drug Revenue in 2022
Figure 23. Hormone Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Dwarfism
Figure 25. Global Dwarfism Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Gigantism
Figure 27. Global Gigantism Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Hormone Disorder Drug Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Hormone Disorder Drug Sales Market Share by Application in 2022 & 2034
Figure 32. North America Hormone Disorder Drug Sales Market Share in Volume by Application in 2022
Figure 33. North America Hormone Disorder Drug Sales Market Share in Value by Application in 2022
Figure 34. Europe Hormone Disorder Drug Sales Market Share in Volume by Application in 2022
Figure 35. Europe Hormone Disorder Drug Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Hormone Disorder Drug Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Hormone Disorder Drug Sales Market Share in Value by Application in 2022
Figure 38. Latin America Hormone Disorder Drug Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Hormone Disorder Drug Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Hormone Disorder Drug Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Hormone Disorder Drug Manufacturing Cost Structure
Figure 43. Hormone Disorder Drug Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries